The Business Research Company’s report on the Influenza Vaccines Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the influenza vaccines market’s growth in recent years?
The rising incidences of seasonal influenza are expected to propel the growth of the influenza vaccine market going forward. Seasonal influenza refers to a respiratory illness caused by influenza viruses that typically circulate and cause infections during specific times of the year, usually in the colder months. This shift has resulted from antigenic drift, population susceptibility, environmental factors, incomplete vaccine coverage, and lack of universal vaccination. Influenza vaccines help in reducing the incidences of seasonal influenza by providing immunization against the circulating strains of the virus. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that during the 2022-2023 flu season, there were approximately 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Therefore, the rising incidences of seasons of influenza are driving the growth of the influenza vaccines market.
Access Your Free Sample of the Global Influenza Vaccines Market Report – Get Insights Now!
Large Volume Parenteral LVP Market Report 2025
How does the future projection of the influenza vaccines market size compare to its historical growth?
The influenza vaccines market size has grown strongly in recent years. It will grow from $7.35 billion in 2024 to $7.9 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to pandemic preparedness, public health initiatives, vaccine effectiveness studies, healthcare professional recommendations, global influenza surveillance
The influenza vaccines market size is expected to see strong growth in the next few years. It will grow to $11.02 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to climate and environmental factors, healthcare accessibility improvement, emergence of new influenza strains, innovation in adjuvants and delivery systems, rising healthcare expenditure. Major trends in the forecast period include wider use of mrna vaccine technology, pediatric immunization focus, seasonal influenza control measures, enhanced vaccination coverage in developing nations, tailored vaccination strategies.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Large Volume Parenteral LVP Market Report 2025
Which key players are shaping the future of the influenza vaccines market?
Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.
What trends will propel the growth and evolution of the influenza vaccines market?
Technologically advanced vaccine production is a key trend gaining popularity in the influenza vaccine market. Companies operating in the influenza vaccine market are adopting advanced vaccine production technologies to sustain their position in the market. For instance, in January 2023, GlaxoSmithKline PLC., a UK-based pharmaceutical and biotechnology company introduced MAPS – Multiple Antigen Presenting System for vaccine development. This technology is providing an innovative way to develop effective vaccines to fight bacteria and viruses. This technology is useful for developing vaccines in a short period in case outbreak of an epidemic or pandemic.
Which regions are expected to become dominant players in the influenza vaccines market?
North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
Large Volume Parenteral LVP Market Report 2025
What are the emerging key segments in the influenza vaccines market, and how are they evolving?
The influenza vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels
Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Large Volume Parenteral LVP Market Report 2025
What defines the structure and scope of the influenza vaccines market?
Influenza vaccines refer to flu vaccines designed to provide immunity against influenza viruses. These are quadrivalent vaccines, designed to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
